コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t swelling and tenderness counts, and global pain assessment).
2 alth Assessment Questionnaire, and patient's pain assessment).
3 e using approaches common for other types of pain assessment.
4 hese findings suggest ML's potential in goat pain assessment.
5 l neurological examination and comprehensive pain assessment.
6 tematic screening, followed by comprehensive pain assessment.
7 use of rescue anesthesia and patient global pain assessment.
8 spinal cord from a rat model for OA-related pain assessment.
9 ing nurses' use of standardized measures for pain assessment.
10 r spine MRI studies are widely used for back pain assessment.
11 ts are a notoriously challenging species for pain assessment.
12 PS), which is the 'golden standard' in sheep pain assessment.
13 h or loss to follow-up for toxic effects and pain assessments.
14 accompanying symptoms, medical history, and pain assessments.
15 functional status, analgesics, and physician pain assessments.
16 ive topics: 1) using a quantitative tool for pain assessment; 2) administering narcotics for pain rel
22 Our objective was to test a method of brief pain assessment and clinical staging based on recognized
23 These findings suggest that comprehensive pain assessment and evidence-based analgesic decision-ma
24 (fNIRS) and virtual reality (VR) to improve pain assessment and explore non-pharmacological pain rel
27 o ensure implementation of key standards for pain assessment and management and education of health p
28 oretical model of decision making related to pain assessment and management for patients with dementi
30 se common myths and misconceptions regarding pain assessment and management in critically ill patient
33 of key palliative care processes (other than pain assessment and management) was inconsistent and inf
36 sion coefficient for the association between pain assessment and race IAT scores was -0.49 (95% CI, -
38 s) completed a questionnaire that included a pain assessment and the 12-item General Health Questionn
39 by clinicians with insufficient knowledge of pain assessment and therapy; inappropriate concerns abou
42 human patients as having higher pain in most pain assessment and treatment domains compared to their
43 racial and ethnic disparities in peripartum pain assessment and treatment is a national priority.
45 ndings underscore the potential of fNIRS for pain assessment and VR as a useful non-pharmacological i
46 pplicability of real-time and video-recorded pain assessment, and their agreement, in young, adult bu
47 iew describes this framework, an approach to pain assessment, and widely accepted techniques to optim
48 ation, analgesia, or neuromuscular blockers, pain assessments, and drug withdrawal syndromes were gat
49 for this highly quantitative methodology in pain assessment (associated with broiler lameness) inclu
50 Visual analogue scales (VAS) were used for pain assessment at rest, for activities of daily living,
51 In the unadjusted analysis, younger age, no pain assessment at triage, opioids, longer duration of s
52 Our statistical software platform, PAWS (Pain Assessment at Withdrawal Speeds), uses a univariate
55 omes were immediate change in mood (Memorial Pain Assessment Card) and 60-second heart and respirator
56 Primary outcomes were immediate (Memorial Pain Assessment Card, 0- to 10-point scale) and sustaine
57 ettings) scores, pain level (assessed by the Pain Assessment Checklist for Seniors With Limited Abili
59 opinions, and attitudes were solicited about pain assessment, current treatment of JIA with residual
61 nsity of pain and should perform descriptive pain assessment for patients with a positive screen, inc
65 the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials guidelines, no pain t
67 although we found a significant increase in pain assessments in the last 24 hours of life (p < 0.001
68 d 8 clinical assessment vignettes focused on pain assessment, informed consent, patient reliability,
72 Ultimately, reliable and valid orofacial pain assessment is a necessary step toward the developme
74 ly assessed and whether routine quantitative pain assessment is feasible in a busy outpatient oncolog
78 s including tender and swollen joint counts, pain assessment on a 10-point visual analog scale, and f
81 rteen registered nurses completed up to five pain assessments on each patient over a 4-hr period.
82 average reduction in numerical rating scale pain assessment (on a 0-10-point scale; weighted mean di
84 l and patient education, instituting regular pain assessment (pain as a vital sign), audit of pain re
86 the intervention was successful in changing pain assessment practices, with pain assessment using st
87 of catheter placement, and type and time of pain assessment, provided better postoperative analgesia
88 owledge and attitudes about pain and nursing pain assessment rates have been shown to be improvable,
91 ndividual (N-of-1) using subjective clinical pain assessments supported by objective validated functi
92 ing, Ocular Surface Disease Index and Ocular Pain Assessment Survey questionnaires were administered,
93 a night shift or not, performed empathy for pain assessment tasks and simulated patient scenarios in
94 The present review describes the progress in pain assessment technology that involves the coding of h
95 and physician global assessments and patient pain assessment than to changes in the joint swelling an
98 ured using modified components of a neonatal pain assessment tool before (baseline) and during OCT im
99 itical Care Pain Observation Tool is a valid pain assessment tool in noncomatose, delirious adult ICU
100 ial expression appears to work reliably as a pain assessment tool with cognitively compromised patien
104 practice behaviours (e.g., documentation of pain assessments, use of non-pharmacological and pharmac
105 in changing pain assessment practices, with pain assessment using standardized measures increasing f
109 viation and confidence intervals for various pain assessments were used as the main outcomes for pre-
110 k pain time points and evidence for referred pain assessment when studying soft tissue augmentation p
111 on level, and will enable the combination of pain assessments with information about activities of da